MoonLake Immunotherapeutics MLTX Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash
Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash at other companies
Other financials
Where this comes from
Reported directly by MoonLake Immunotherapeutics in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.
The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about MoonLake Immunotherapeutics's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is MoonLake Immunotherapeutics's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash?
- MoonLake Immunotherapeutics (MLTX) reported effect of currency exchange rate changes on cash, cash equivalents, and restricted cash of -$483K in Q1 2026.
- How has MoonLake Immunotherapeutics's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash changed year-over-year?
- MoonLake Immunotherapeutics's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash decreased by 448.9% year-over-year, from -$88K to -$483K.